GPSM2 antibody

Cat.#: 111144

Size:

Special Price 239.0 USD

Availability: In Stock
- +

Add to cart to get an online quotation

Product Information

  • Product Name
    GPSM2 antibody
  • Documents
  • Description
    GPSM2 Rabbit Polyclonal antibody. Positive IHC detected in human pancreas cancer tissue. Positive WB detected in HeLa cells, human brain tissue. Observed molecular weight by Western-blot: 66-70 kDa
  • Tested applications
    ELISA, WB, IHC
  • Species reactivity
    Human; other species not tested.
  • Alternative names
    GPSM2 antibody; LGN antibody; Mosaic protein LGN antibody; Pins antibody
  • Isotype
    Rabbit IgG
  • Preparation
    This antibody was obtained by immunization of GPSM2 recombinant protein (Accession Number: BC027732). Purification method: Antigen affinity purified.
  • Clonality
    Polyclonal
  • Formulation
    PBS with 0.1% sodium azide and 50% glycerol pH 7.3.
  • Storage instructions
    Store at -20℃. DO NOT ALIQUOT
  • Applications

    Recommended Dilution:

    WB: 1:200-1:2000

    IHC: 1:20-1:200

  • Validations

    HeLa cells were subjected to SDS PAGE followed by western blot with Catalog No:111144(GPSM2 antibody) at dilution of 1:500

    HeLa cells were subjected to SDS PAGE followed by western blot with Catalog No:111144(GPSM2 antibody) at dilution of 1:500

    Immunohistochemical of paraffin-embedded human pancreas cancer using Catalog No:111144(GPSM2 antibody) at dilution of 1:50 (under 10x lens)

    Immunohistochemical of paraffin-embedded human pancreas cancer using Catalog No:111144(GPSM2 antibody) at dilution of 1:50 (under 10x lens)

  • Background
    GPSM2 belongs to a family of proteins that modulate activation of G proteins, which transduce extracellular signals received by cell surface receptors into integrated cellular responses. It may play a role in neuroblast division and in the development of normal hearing. Mutations in GPSM2 are associated with autosomal recessive nonsyndromic deafness (DFNB82), which is a form of non-syndromic deafness characterized by prelingual, bilateral, severe, sensorineural hearing loss.
  • References
    • Fukukawa C, Ueda K, Nishidate T, Katagiri T, Nakamura Y. Critical roles of LGN/GPSM2 phosphorylation by PBK/TOPK in cell division of breast cancer cells. Genes, chromosomes & cancer. 49(10):861-72. 2010.
    • Seldin L, Poulson ND, Foote HP, Lechler T. NuMA localization, stability, and function in spindle orientation involve 4.1 and Cdk1 interactions. Molecular biology of the cell. 24(23):3651-62. 2013.
    • Bhonker Y, Abu-Rayyan A, Ushakov K. The GPSM2/LGN GoLoco motifs are essential for hearing. Mammalian genome : official journal of the International Mammalian Genome Society. 27(1-2):29-46. 2016.
    • Guo X, Gao S. Pins homolog LGN regulates meiotic spindle organization in mouse oocytes. Cell research. 19(7):838-48. 2009.
    • Walsh T, Shahin H, Elkan-Miller T. Whole exome sequencing and homozygosity mapping identify mutation in the cell polarity protein GPSM2 as the cause of nonsyndromic hearing loss DFNB82. American journal of human genetics. 87(1):90-4. 2010.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"